Testosterone Therapy for Women Faces Pharmacy Roadblocks

Women are increasingly seeking testosterone therapy to manage menopause symptoms, but are facing unexpected prescription delays and denials at pharmacies. This trend is occurring despite the absence of any U.S.-approved testosterone product for women. Clinicians are prescribing it off-label, primarily for low sexual desire, though some also use it for fatigue and muscle loss, unsupported by medical guidelines.

Compounding pharmacies are often used to create customized doses, but these treatments can cost approximately $100 for a three-month supply, compared to a commercial pharmacy's $30 for ten months. Most insurance providers do not cover testosterone for women, adding to the financial burden. Some pharmacies, like Amazon Pharmacy, have implemented new policies that reject prescriptions requiring dose customization, citing safety and compliance.

Over 30 trials are currently investigating testosterone use in women for various conditions, with some companies developing next-generation products. The U.S. Food and Drug Administration plans to hold a public workshop to review the evidence for testosterone's use in menopausal women. Pharmacies may decline prescriptions due to concerns over dosing accuracy, medication safety, and proper handling of controlled substances.